-
1
-
-
49649119977
-
Giant cell tumor of bone: treatment and outcome of 214 cases
-
Balke M, Schremper L, Gebert C, et al. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 2008, 134:969-978.
-
(2008)
J Cancer Res Clin Oncol
, vol.134
, pp. 969-978
-
-
Balke, M.1
Schremper, L.2
Gebert, C.3
-
2
-
-
24344444472
-
Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue
-
Lau YS, Sabokbar A, Gibbons CL, Giele H, Athanasou N Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Hum Pathol 2005, 36:945-954.
-
(2005)
Hum Pathol
, vol.36
, pp. 945-954
-
-
Lau, Y.S.1
Sabokbar, A.2
Gibbons, C.L.3
Giele, H.4
Athanasou, N.5
-
3
-
-
33845381060
-
Giant cell tumour of bone: morphological, biological and histogenetical aspects
-
Werner M Giant cell tumour of bone: morphological, biological and histogenetical aspects. Int Orthop 2006, 30:484-489.
-
(2006)
Int Orthop
, vol.30
, pp. 484-489
-
-
Werner, M.1
-
4
-
-
37349083874
-
Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study
-
Tse LF, Wong KC, Kumta SM, Huang L, Chow TC, Griffith JF Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study. Bone 2008, 42:68-73.
-
(2008)
Bone
, vol.42
, pp. 68-73
-
-
Tse, L.F.1
Wong, K.C.2
Kumta, S.M.3
Huang, L.4
Chow, T.C.5
Griffith, J.F.6
-
5
-
-
84871531993
-
Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonates
-
Yu X, Xu M, Xu S, Su Q Clinical outcomes of giant cell tumor of bone treated with bone cement filling and internal fixation, and oral bisphosphonates. Oncol Lett 2013, 5:447-451.
-
(2013)
Oncol Lett
, vol.5
, pp. 447-451
-
-
Yu, X.1
Xu, M.2
Xu, S.3
Su, Q.4
-
6
-
-
77956462309
-
Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone
-
Balke M, Campanacci L, Gebert C, et al. Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer 2010, 10:462.
-
(2010)
BMC Cancer
, vol.10
, pp. 462
-
-
Balke, M.1
Campanacci, L.2
Gebert, C.3
-
7
-
-
84865073466
-
Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone
-
Branstetter DG, Nelson SD, Manivel JC, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res 2012, 18:4415-4424.
-
(2012)
Clin Cancer Res
, vol.18
, pp. 4415-4424
-
-
Branstetter, D.G.1
Nelson, S.D.2
Manivel, J.C.3
-
8
-
-
77349120482
-
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
-
Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol 2010, 11:275-280.
-
(2010)
Lancet Oncol
, vol.11
, pp. 275-280
-
-
Thomas, D.1
Henshaw, R.2
Skubitz, K.3
-
9
-
-
84880770534
-
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
-
published online July 16.
-
Chawla S, Henshaw R, Seeger L, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol 2013, published online July 16. http://dx.doi.org/10.1016/S1470-2045(13)70277-8.
-
(2013)
Lancet Oncol
-
-
Chawla, S.1
Henshaw, R.2
Seeger, L.3
|